ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01149122
Recruitment Status : Completed
First Posted : June 23, 2010
Last Update Posted : May 15, 2014
Sponsor:
Information provided by (Responsible Party):
Samsung Medical Center